Published in Euro Surveill on August 07, 2014
Capture-Recapture Estimators in Epidemiology with Applications to Pertussis and Pneumococcal Invasive Disease Surveillance. PLoS One (2016) 1.40
Anti-Pneumococcal Capsular Polysaccharide Antibody Response and CD5 B Lymphocyte Subsets. Infect Immun (2015) 0.76
Effectiveness of 23-valent pneumococcal polysaccharide vaccination in preventing community-acquired pneumonia hospitalization and severe outcomes in the elderly in Spain. PLoS One (2017) 0.75
The ABC of pneumococcal infections and vaccination in patients with chronic kidney disease. Clin Kidney J (2015) 0.75
Study of Invasive Pneumococcal Infection in Adults with Reference to Penicillin Resistance. J Lab Physicians (2017) 0.75
Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium. Clin Microbiol Infect (2007) 3.49
Social mixing patterns for transmission models of close contact infections: exploring self-evaluation and diary-based data collection through a web-based interface. Epidemiol Infect (2006) 3.39
Early waning of maternal measles antibodies in era of measles elimination: longitudinal study. BMJ (2010) 2.80
Remediastinoscopy after neoadjuvant therapy for non-small cell lung cancer. Lung Cancer (2002) 2.68
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm. J Viral Hepat (2014) 2.23
Passive transmission and persistence of naturally acquired or vaccine-induced maternal antibodies against measles in newborns. Vaccine (2007) 2.08
The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis. Biochim Biophys Acta (2006) 1.79
Historical epidemiology of hepatitis C virus (HCV) in selected countries. J Viral Hepat (2014) 1.68
Strategies to manage hepatitis C virus (HCV) disease burden. J Viral Hepat (2014) 1.67
Quantification of HIV-1 RNA in plasma: comparable results with the NASBA HIV-1 RNA QT and the AMPLICOR HIV monitor test. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.60
Interleukin 8 (IL-8) in the bronchoalveolar lavage fluid from patients with the adult respiratory distress syndrome (ARDS) and patients at risk for ARDS. Cytokine (1992) 1.58
Progranulin genetic variability contributes to amyotrophic lateral sclerosis. Neurology (2008) 1.56
Management of obstructive sleep apnea in Europe. Sleep Med (2010) 1.56
Hepatitis B vaccine -- do we need boosters? J Viral Hepat (2003) 1.49
The seroepidemiology of herpes simplex virus type 1 and 2 in Europe. Sex Transm Infect (2004) 1.49
Lung function and bronchodilator response in 4-year-old children with different wheezing phenotypes. Eur Respir J (2009) 1.49
Mosaic 13 trisomy due to de novo 13/13 translocation with subsequent fission. Karyotype: 46,XX,-13, +t(13;13)(p11;q11)/46,XX,del(13)(p11). A second example. Ann Genet (1989) 1.46
Interference of antibody production to hepatitis B surface antigen in a combination hepatitis A/hepatitis B vaccine. J Infect Dis (1999) 1.45
Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory. Vaccine (2000) 1.44
Spherocytosis and pulmonary hypertension coincidental occurrence or causal relationship? Eur Respir J (1991) 1.43
Single-drug versus combination empirical therapy for gram-negative bacillary infections in febrile cancer patients with and without granulocytopenia. Antimicrob Agents Chemother (1984) 1.41
Detection of human papillomavirus DNA in urine. A review of the literature. Eur J Clin Microbiol Infect Dis (2011) 1.36
Hepatitis A booster vaccination: is there a need? Lancet (2003) 1.32
Therapeutic electrical stimulation of the hypoglossal nerve in obstructive sleep apnea. Arch Otolaryngol Head Neck Surg (2001) 1.32
Cost-effectiveness analysis of prenatal screening and vaccination against hepatitis B virus--the case of Belgium. Soc Sci Med (1993) 1.29
Serum bactericidal activity of ceftazidime and cefoperazone alone or in combination with amikacin against Pseudomonas aeruginosa and Klebsiella pneumoniae. Antimicrob Agents Chemother (1983) 1.29
Increased prevalence of sleep disturbances and daytime sleepiness in subjects with bronchial asthma: a population study of young adults in three European countries. Eur Respir J (1996) 1.25
Clinical use of the meropenem-clavulanate combination for extensively drug-resistant tuberculosis. Int J Tuberc Lung Dis (2012) 1.23
Upper and lower gastrointestinal evaluation of elderly inpatients who are iron deficient. Am J Med (1999) 1.23
Flow analyses in the lower airways: patient-specific model and boundary conditions. Med Eng Phys (2007) 1.22
Clinical evaluation of the Copan ESwab for methicillin-resistant Staphylococcus aureus detection and culture of wounds. Eur J Clin Microbiol Infect Dis (2011) 1.20
Costs and benefits of routine varicella vaccination in German children. J Infect Dis (1996) 1.17
Cost-effectiveness analysis of hepatitis A prevention in travellers. Vaccine (1992) 1.17
TDP-43 M311V mutation in familial amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry (2009) 1.17
A 62-month retrospective epidemiological survey of anaerobic bacteraemia in a university hospital. Clin Microbiol Infect (2006) 1.16
Mechanistic insight into taxol-induced cell death. Oncogene (2008) 1.15
Public health and medicolegal implications of sleep apnoea. Eur Respir J (2002) 1.14
High-dose cefepime as an alternative treatment for infections caused by TEM-24 ESBL-producing Enterobacter aerogenes in severely-ill patients. Clin Microbiol Infect (2006) 1.13
The European Sleep Apnoea Database (ESADA): report from 22 European sleep laboratories. Eur Respir J (2011) 1.11
Prevalence of sleep disturbances among young adults in three European countries. Sleep (1995) 1.11
Relevance of a systematic geriatric screening and assessment in older patients with cancer: results of a prospective multicentric study. Ann Oncol (2013) 1.10
The state of hepatitis B and C in the Mediterranean and Balkan countries: report from a summit conference. J Viral Hepat (2013) 1.10
A single dose, combined vaccine against typhoid fever and hepatitis A: consistency, immunogenicity and reactogenicity. J Travel Med (2001) 1.10
Mutations in SACS cause atypical and late-onset forms of ARSACS. Neurology (2010) 1.10
Pertussis vaccination and pregnancy. Clin Infect Dis (2013) 1.09
Seventy-five years of estimating the force of infection from current status data. Epidemiol Infect (2009) 1.08
Hepatitis B vaccination for sex workers: do outreach programmes perform better? Sex Transm Infect (2003) 1.08
Hepatitis B and C in institutions for individuals with intellectual disability. J Intellect Disabil Res (1999) 1.07
Safety and immunogenicity of a hepatitis B vaccine formulated with a novel adjuvant system. Vaccine (1998) 1.07
Computational fluid dynamics can detect changes in airway resistance in asthmatics after acute bronchodilation. J Biomech (2007) 1.07
Hepatitis B virus, hepatitis C virus and other blood-borne infections in healthcare workers: guidelines for prevention and management in industrialised countries. Occup Environ Med (2008) 1.05
Use of ceftazidime in the therapy of serious infections, including those due to multiresistant organisms. Antimicrob Agents Chemother (1983) 1.04
Measles outbreak in Europe: susceptibility of infants too young to be immunized. Vaccine (2012) 1.02
Correlation between severity of sleep apnea and upper airway morphology based on advanced anatomical and functional imaging. J Biomech (2006) 1.02
Fractures, physical activity, and growth velocity in adolescent Belgian boys. Med Sci Sports Exerc (1993) 1.02
Analysis of factors influencing vaccine uptake: perspectives from Belgium. Vaccine (2001) 1.02
Long-term persistence of anti-HBs after vaccination with a recombinant DNA yeast-derived hepatitis B vaccine: 8-year results. Vaccine (1998) 1.00
Assessment of respiratory effort by means of strain gauges and esophageal pressure swings: a comparative study. Sleep (1997) 1.00
Origin and transmission of methicillin-resistant Staphylococcus aureus in an endemic situation: differences between geriatric and intensive-care patients. J Hosp Infect (1997) 1.00
Has the time come to control hepatitis A globally? Matching prevention to the changing epidemiology. J Viral Hepat (2008) 1.00
The effects of long-term noninvasive ventilation in hypercapnic COPD patients: a randomized controlled pilot study. Int J Chron Obstruct Pulmon Dis (2011) 1.00
Mutant hepatitis B viruses: a matter of academic interest only or a problem with far-reaching implications? Vaccine (2001) 1.00
Prevention of hepatitis C virus infection. J Viral Hepat (2004) 0.99
Diphtheria immunity in Flanders. Eur J Clin Microbiol Infect Dis (1997) 0.99
Higher proportion of G2P[4] rotaviruses in vaccinated hospitalized cases compared with unvaccinated hospitalized cases, despite high vaccine effectiveness against heterotypic G2P[4] rotaviruses. Clin Microbiol Infect (2014) 0.99
Cardiovascular mechanisms and consequences of obstructive sleep apnoea. Acta Clin Belg (2013) 0.98
Inactivated hepatitis A vaccine-induced antibodies: follow-up and estimates of long-term persistence. J Med Virol (2001) 0.98
Daytime sleepiness, snoring and gastro-oesophageal reflux amongst young adults in three European countries. J Intern Med (1995) 0.97
Prevalence of hepatitis A, B and C in the Flemish population. Eur J Epidemiol (1997) 0.96
Behavioural aspects of travellers in their use of malaria presumptive treatment. Bull World Health Organ (1995) 0.94
Serum bactericidal activity of cefoperazone and ceftazidime at increasing dosages against Pseudomonas aeruginosa. J Antimicrob Chemother (1983) 0.94
Kinetics of maternal antibodies against rubella and varicella in infants. Vaccine (2010) 0.93
Massive cerebral infarction after completion pneumonectomy for pulmonary torsion. Thorax (1994) 0.93
Are we hitting immunity targets? The 2006 age-specific seroprevalence of measles, mumps, rubella, diphtheria and tetanus in Belgium. Epidemiol Infect (2010) 0.93
Viral hepatitis and pregnancy. Acta Gastroenterol Belg (1999) 0.93
A summer school on vaccinology: Responding to identified gaps in pre-service immunisation training of future health care workers. Vaccine (2009) 0.93
Phylogenetic analysis of the highland papayas ( Vasconcellea) and allied genera (Caricaceae) using PCR-RFLP. Theor Appl Genet (2004) 0.92
Assessment of progression of COPD: report of a workshop held in Leuven, 11-12 March 2004. Thorax (2005) 0.91
Phase II double-blind, placebo-controlled study of the safety and efficacy of cidofovir topical gel for the treatment of patients with human papillomavirus infection. Clin Infect Dis (2001) 0.91
Ceftazidime as a single agent in the treatment of severe Pseudomonas aeruginosa infections. J Antimicrob Chemother (1983) 0.91
Response to diphtheria booster vaccination in healthy adults: vaccine trial. BMJ (2000) 0.91
Rotavirus vaccination coverage and adherence to recommended age among infants in Flanders (Belgium) in 2012. Euro Surveill (2014) 0.91
Serum bactericidal activity of aztreonam, cefoperazone, and amikacin, alone or in combination, against Escherichia coli, Klebsiella pneumoniae, Serratia marcescens, and Pseudomonas aeruginosa. Antimicrob Agents Chemother (1984) 0.91
Optimization of HPV DNA detection in urine by improving collection, storage, and extraction. Eur J Clin Microbiol Infect Dis (2014) 0.91
Interleukin-8 production in patients undergoing cardiopulmonary bypass. The influence of pretreatment with methylprednisolone. Am Rev Respir Dis (1993) 0.90
Evidence for a substantial role of sharing of injecting paraphernalia other than syringes/needles to the spread of hepatitis C among injecting drug users. J Viral Hepat (2006) 0.90
Male sex workers in Antwerp, Belgium: a descriptive study. Int J STD AIDS (2005) 0.90
Schedules for hepatitis B vaccination of risk groups: balancing immunogenicity and compliance. Sex Transm Infect (2007) 0.90
Molecular epidemiology of hepatitis C among drug users in Flanders, Belgium: association of genotype with clinical parameters and with sex- and drug-related risk behaviours. Eur J Clin Microbiol Infect Dis (2005) 0.90
High pressure liquid chromatographic quantitation of teicoplanin in human serum. J Antimicrob Chemother (1987) 0.89
Antimicrobial activity of traditional medicinal plants from Ankober District, North Shewa Zone, Amhara Region, Ethiopia. Pharm Biol (2014) 0.89
Comparative serum bactericidal activity against test anaerobes in volunteers receiving imipenem, clindamycin, latamoxef and metronidazole. J Antimicrob Chemother (1987) 0.89
Hepatitis E virus infection in travelers. Clin Infect Dis (1999) 0.89
Mathematical models for assessment of long-term persistence of antibodies after vaccination with two inactivated hepatitis A vaccines. J Med Virol (2000) 0.89
Is the prevalence of hepatitis C virus (HCV) RNA in anti-HCV-positive injection drug users positively correlated with age? J Infect Dis (2001) 0.88
Hypercalciuria in the syndrome of inappropriate secretion of antidiuretic hormone. Miner Electrolyte Metab (1982) 0.88
Sweet's syndrome in an HIV-infected patient. AIDS (1999) 0.88